Pneumococcal Vaccine Schedule: Adults

PNEUMOCOCCAL VACCINE SCHEDULE: ADULTS
PNEUMOCOCCAL VACCINE SCHEDULE: ADULTS
Patient Criteria Vaccine History Initial Vaccine Minimum Interval for Subsequent Vaccine
≥8 weeks ≥1 year ≥5 years
AGE ≥65 YEARS
Immunocompetent None1 PCV20      
OR
PCV15 PPSV23
PPSV23 only (at any age) —   PCV20  
OR
—   PCV15  
PCV13 only (at any age) —   PCV20  
OR
—   PPSV23  
PCV13 (at any age) and PPSV23 (at <65yrs) —     PCV20
OR
—   PPSV232
PCV13 (at any age) and PPSV23 (at ≥65yrs) —     PCV203
With an immunocompromising condition4, cochlear implant, or CSF leak None1 PCV20      
OR
PCV15 PPSV23    
PPSV23 only (at any age) —   PCV20  
OR
—   PCV15  
PCV13 only (at any age) —   PCV20  
OR
— PPSV23    
PCV13 (at any age) & PPSV23 (at <65yrs) —     PCV20
OR
— PPSV235
PCV13 (at any age) & PPSV23 (at ≥65yrs) —     PCV20
AGE 19−64 YEARS
With an immunocompromising condition4 None1 PCV20      
OR
PCV15 PPSV23    
PPSV23 only —   PCV20  
OR
—   PCV15  
PCV13 only —   PCV20  
OR
— PPSV23   PPSV236
PCV13 and 1 dose PPSV23 —     PCV20
OR
— PPSV235,6
PCV13 and 2 doses PPSV23 —     PCV20
OR
— None6,7
With cochlear implant or CSF leak None1 PCV20      
OR
PCV15 PPSV23    
PPSV23 only —   PCV20  
OR
—   PCV15  
PCV13 only —   PCV20  
OR
— PPSV236    
PCV13 and 1 dose PPSV23 —     PCV20
OR
— None6,7
With a chronic medical condition8 None1 PCV20      
OR
PCV15   PPSV23  
PPSV23 only —   PCV20  
OR
—   PCV15  
PCV139 only —   PCV20  
OR
—   PPSV236  
PCV139 and PPSV23 — None6,7
NOTES

Key:CSF = cerebrospinal fluid; PCV = pneumococcal conjugate vaccine; PPSV = pneumococcal polysaccharide vaccine

 1 Also applies to receipt of PCV7 at any age and no other pneumococcal vaccines.

 2 The minimum interval for PPSV23 is ≥1yr since last PCV13 dose and ≥5yrs since last PPSV23 dose.

 3 Based on shared clinical decision-making with the patient, vaccine providers may choose to administer PCV20 to those who have already completed the series with PCV13 and PPSV23.

 4 Immunocompromising conditions include chronic renal failure, congenital or acquired asplenia, congenital or acquired immunodeficiency (eg, B- or T-lymphocyte deficiency, complement deficiencies [particularly C1, C2, C3, and C4 deficiencies], phagocytic disorders [excluding chronic granulomatous disease]), generalized malignancy, HIV infection, Hodgkin disease, iatrogenic immunosuppression (eg, treatment with immunosuppressants, including long-term systemic corticosteroids, radiation), leukemia, lymphoma, multiple myeloma, nephrotic syndrome, sickle cell disease/other hemoglobinopathies, solid organ transplant.

 5 The minimum interval for PPSV23 is ≥8wks since last PCV13 dose and ≥5yrs since last PPSV23 dose in adults ≥65yrs with an immunocompromising condition, cochlear implant, or CSF leak, or in adults 19–64yrs with immunocompromising condition.

 6 Review pneumococcal vaccine recommendations again when patient turns 65yrs old.

 7 No vaccines recommended at this time.

 8 Chronic medical conditions include alcoholism, chronic heart disease (eg, CHF, cardiomyopathies), chronic liver disease, chronic lung disease (eg, COPD, emphysema, asthma), cigarette smoking, diabetes.

 9 Adults with chronic medical conditions were previously not recommended to receive PCV13.

REFERENCES

Centers for Disease Control and Prevention. Pneumococcal Vaccine Timing for Adults. Accessed March 15, 2023. https://www.cdc.gov/vaccines/vpd/pneumo/downloads/pneumo-vaccine-timing.pdf.

Created 6/2023